Transient left ventricular dysfunction following chimeric antigen receptor T‐cell‐mediated encephalopathy: A form of stress cardiomyopathy

Chimeric antigen receptor (CAR) T‐cell therapy represents a new strategy in treating lymphoid malignancies, such as relapsed‐refractory diffuse large B‐cell lymphoma (DLBCL). Several toxicities including cytokine release syndrome (CRS), neurotoxicity, and cardiovascular toxicity have been linked to...

Descripción completa

Detalles Bibliográficos
Autores principales: Khorasanchi, Adam, Ansari, Amir M., Bottinor, Wendy, Simmons, Gary, Abbate, Antonio, Toor, Amir A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175695/
https://www.ncbi.nlm.nih.gov/pubmed/35846197
http://dx.doi.org/10.1002/jha2.369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175695/
https://www.ncbi.nlm.nih.gov/pubmed/35846197
http://dx.doi.org/10.1002/jha2.369

Ejemplares similares